Related Experiment Video
Updated: Feb 18, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Proton Therapy for Head and Neck Cancers.
Pierre Blanchard1, Gary Brandon Gunn2, Alexander Lin3
1Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Radiation Oncology, Institut Gustave Roussy, Villejuif, France.
Proton therapy provides superior dose distribution compared to photon therapy for head and neck cancers. This review examines its physical advantages, clinical benefits across various sites, and considerations for patient selection and cost-effectiveness.
Area of Science:
- Medical Physics
- Radiation Oncology
Background:
- Proton therapy offers dosimetric advantages due to its sharp lateral penumbra and steep distal fall-off.
- Historically used for skull-base tumors, its application in head and neck cancers has expanded.
- Expanded applications include nasopharynx, oropharynx, nasal cavity, paranasal sinuses, periorbital, skin, salivary gland tumors, and reirradiation.
Purpose of the Study:
- To review the physical properties and dosimetric benefits of proton therapy versus advanced photon therapy.
- To summarize the clinical benefits of proton therapy for various head and neck cancer sites.
- To discuss patient selection criteria and cost-effectiveness of proton therapy.
Main Methods:
- Literature review of physical properties and dosimetric data.
- Synthesis of clinical outcomes from studies on various head and neck cancer sites.
- Analysis of patient selection factors and economic evaluations.
Main Results:
- Proton therapy demonstrates superior dose distribution, reducing radiation exposure to surrounding healthy tissues.
- Evidence suggests clinical benefits in multiple head and neck cancer sites, including improved outcomes and reduced toxicity.
- Key considerations for implementation include patient selection and cost-effectiveness analysis.
Conclusions:
- Proton therapy presents significant dosimetric and potential clinical advantages for head and neck cancer treatment.
- Further research and careful patient selection are crucial for optimizing its use and addressing cost concerns.
More Related Videos
06:11Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Related Concept Videos
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists